Exciting lecture on "Superselective Intraarterial Cerebral Infusion of Bevacizumab (Avastin)" to be presented at CNJBTSG meeting this Thursday
Posted on: 07/31/2012
Exciting lecture to be presented at CNJBTSG meeting this Thursday :
John A. Boockvar, MD
Associate Professor of Neurosurgery
Director, Brain Tumor and Stem Cell Laboratory
Weill Cornell Medical College
New York/Presbyterian Hospital
Will be speaking about a new way to use Avastin for brain tumors: Super Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin). This experimental technique allows a much higher dose of Avastin to where it is needed.
It will be presented at the Central NJ Brain Tumor Support Group Meeting
When: Thursday August 2, 2012
Time 7:00 P.M. - 8:30 P.M.
Location NJ Neuroscience Center at JFK Medical Center, 65 James St, Edison, NJ 08818
There is no charge, but space is limited. Please respond to this (email@example.com) if you want to attend. Tell me how many people you will be bringing.
Click HERE to return to brain tumor news headlines